Pfizer seeking emergency use of its COVID-19 vaccine in US

Pfizer said Friday it is asking U.S. regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic -- but not until after a long, hard winter.

Posted: Nov 20, 2020 12:21 PM

Pfizer said Friday it is asking U.S. regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic -- but not until after a long, hard winter.

The action comes days after Pfizer Inc. and its German partner BioNTech announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.

The companies said that protection plus a good safety record means the vaccine should qualify for emergency use authorization, something the Food and Drug Administration can grant before the final testing is fully complete. In addition to Friday’s FDA submission, they have already started “rolling” applications in Europe and the U.K. and intend to submit similar information soon.

“Our work to deliver a safe and effective vaccine has never been more urgent,” Pfizer CEO Albert Bourla said in a statement.

With the coronavirus surging around the U.S. and the world, the pressure is on for regulators to make a speedy decision.

“Help is on the way,” Dr. Anthony Fauci, the top U.S. infectious disease expert said on the eve of Pfizer’s announcement, adding that it’s too early to abandon masks and other protective measures. “We need to actually double down on the public health measures as we’re waiting for that help to come.”

Friday’s filing would set off a chain of events as the FDA and its independent advisers debate if the shots are ready. If so, still another government group will have to decide how the initial limited supplies are rationed out to anxiously awaiting Americans.

How much vaccine is available and when is a moving target, but initial supplies will be scarce and rationed. Globally, Pfizer has estimated it could have 50 million doses available by year’s end.

About 25 million may become available for U.S. use in December, 30 million in January and 35 million more in February and March, according to information presented to the National Academy of Medicine this week. Recipients will need two doses, three weeks apart. The U.S. government has a contract to buy millions of Pfizer-BioNTech doses, as well as other candidates than pan out, and has promised shots will be free.

Not far behind is competitor Moderna Inc.’s COVID-19 vaccine. Its early data suggests the shots are as strong as Pfizer’s, and that company expects to also seek emergency authorization within weeks.

Here’s what happens next:

MAKING THE DATA PUBLIC

The public’s first chance to see how strong the evidence really is will come in early December at a public meeting of the FDA’s scientific advisers.

So far, what’s known is based only on statements from Pfizer and BioNTech. Of 170 infections detected to date, only eight were among people who’d received the actual vaccine and the rest had gotten a dummy shot. On the safety side, the companies cite results from 38,000 study participants who’ve been tracked for two months after their second dose. That’s a milestone FDA set because historically, vaccine side effects don’t crop up later than that.

“We’ll drill down on these data,” said FDA adviser Dr. Paul Offit of the Children’s Hospital of Philadelphia.

Think of it like science on trial. A few days before the meeting, the FDA will release its own internal analysis. That sets the stage for the advisers’ daylong debate about any signs of safety concerns and how the new vaccine technology works before rendering a verdict.

They’ll recommend not just whether FDA should allow broader use of the vaccine generally but if so, for whom. For example, is there enough proof the vaccine works as well for older, sicker adults as for younger, healthier people?

There’s still no guarantee. “We don’t know what that vote’s going to be,” said former FDA vaccine chief Norman Baylor.

EMERGENCY USE ISN’T THE SAME AS FULL APPROVAL

If there’s an emergency green light, “that vaccine is still deemed investigational. It’s not approved yet,” Dr. Marion Gruber, chief of FDA’s vaccine office, told the National Academy of Medicine this week.

That means anyone offered an emergency vaccination must get a “fact sheet” describing potential benefits and risks before going through with the shot, she said.

There will be a lot of unknowns. For example, the 95% protection rate is based on people who developed symptoms and then were tested for the virus. Can the vaccinated get infected but have no symptoms, able to spread the virus? How long does protection last?

That’s why the 44,000-person study needs to keep running -- something difficult considering ethically, participants given dummy shots at some point must be offered real vaccine, complicating the search for answers.

“I’m curious,” said Barry Colvin, 52, of White Plains, New York, who is taking part in that study at NYU Langone Health.

But he’s not in a great hurry to find out which group he’s in. “You need to hang in there for a while to understand and answer a lot of the other questions that remain unknown.”

Additionally at least for now, pregnant women won’t qualify because they weren’t studied. Pfizer only recently began testing the vaccine in children as young as 12.

A decision on Pfizer-BioNTech’s vaccine won’t affect other COVID-19 vaccine candidates in the pipeline, which will be judged separately.

MANUFACTURING

Brewing vaccine is more complex than typical drug manufacturing, yet the millionth dose to roll out of Pfizer’s Kalamazoo, Michigan, factory must be the same purity and potency as every dose before and after.

That means the FDA decision isn’t just based on study data, but on its determination that the vaccine is being made correctly.

The Pfizer-BioNTech vaccine -- and Moderna’s shots -- are made with brand-new technology. They don’t contain the actual coronavirus. Instead, they’re made with a piece of genetic code for the “spike” protein that studs the virus.

That messenger RNA, or mRNA, instructs the body to make some harmless spike protein, training immune cells to recognize it if the real virus eventually comes along.

GETTING INTO PEOPLE’S ARMS

Another government group -- advisers to the Centers for Disease Control and Prevention -- decides who is first in line for scarce doses. Health and Human Services Secretary Alex Azar said he hopes that decision can be made at the same time as FDA’s.

The Trump administration’s Operation Warp Speed has worked with states to line up how many doses they’d need to cover the populations offered vaccine first.

Pfizer will ship those supplies as ordered by the states -- only after FDA gives the OK.

Company projections of how much it will ship each month are just predictions, Baylor warned.

“It’s not like a pizza,” he said. Manufacturing is so complex that “you don’t necessarily end up with what you thought.”

___

AP video journalist Kathy Young contributed to this report.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Terre Haute
Clear
35° wxIcon
Hi: 49° Lo: 26°
Feels Like: 31°
Robinson
Clear
32° wxIcon
Hi: 47° Lo: 24°
Feels Like: 32°
Indianapolis
Clear
33° wxIcon
Hi: 48° Lo: 29°
Feels Like: 27°
Rockville
Clear
30° wxIcon
Hi: 48° Lo: 26°
Feels Like: 30°
Casey
Clear
33° wxIcon
Hi: 46° Lo: 26°
Feels Like: 29°
Brazil
Clear
35° wxIcon
Hi: 48° Lo: 25°
Feels Like: 31°
Marshall
Clear
35° wxIcon
Hi: 47° Lo: 26°
Feels Like: 31°
A cold front moves in tonight
WTHI Planner
WTHI Temps
WTHI Radar

Latest Video

Image

GBB West Vigo ITP 12-4-20

Image

GBB THN ITP 12-4-20

Image

GBB PARKE HERITAGE ITP 12-4-20

Image

GBB NORTH VERMILLION ITP 12-4-20

Image

South Vermillion ITP 12-4-20

Image

Parke Heritage ITP 12-4-20

Image

Vin Lin ITP 12-4-20

Image

North Knox ITP 12-4-20

Image

West Vigo ITP 12-4-20

Image

THS ITP 12-4-20

WTHI Events

 

Illinois Coronavirus Cases

(Widget updates once daily at 7 p.m. CT)

Cases: 759562

Reported Deaths: 13624
CountyCasesDeaths
Cook3183246823
DuPage48499821
Will41204590
Lake39051663
Kane33273488
Winnebago19765284
Madison15363270
McHenry14996167
St. Clair14160269
Champaign1133660
Sangamon10669107
Peoria9785139
Kankakee9105114
Rock Island8981152
McLean896159
Tazewell7415118
Macon6817141
Kendall665854
LaSalle6471144
DeKalb528049
Adams494155
Vermilion421859
Boone408135
Whiteside3953131
Williamson385988
Clinton349163
Coles345461
Ogle303845
Knox299374
Effingham298527
Grundy298524
Henry286122
Jackson284237
Marion265566
Stephenson258238
Macoupin241423
Randolph241426
Livingston238738
Morgan233050
Bureau222455
Franklin220427
Monroe219148
Lee211338
Jefferson202663
Christian196943
Woodford191631
Fayette191236
Logan188622
Iroquois183633
McDonough164344
Fulton161414
Shelby146326
Douglas144718
Jersey138424
Union125628
Montgomery124020
Perry118431
Lawrence118314
Crawford118014
Saline117929
Warren114822
Bond114311
Jo Daviess113820
Carroll110927
Cass107023
Pike106331
Hancock101016
Moultrie96911
Wayne96833
Clay93622
Greene89432
Edgar88517
Richland86819
Clark83820
Piatt8295
Ford82024
Mercer80012
Washington7802
Mason77723
Johnson7757
Jasper69512
Cumberland68319
White66410
De Witt65518
Massac6475
Wabash6469
Menard5162
Pulaski4512
Marshall4357
Hamilton4114
Schuyler3431
Brown3376
Henderson3061
Stark3045
Calhoun2781
Alexander2684
Putnam2560
Scott2510
Edwards2423
Gallatin2133
Unassigned2130
Hardin1612
Pope1111
Out of IL100

Indiana Coronavirus Cases

(Widget updates once daily at 8 p.m. ET)

Cases: 359430

Reported Deaths: 6033
CountyCasesDeaths
Marion48740894
Lake30537484
Allen20668338
St. Joseph19177245
Elkhart18813246
Hamilton15457182
Vanderburgh10956137
Tippecanoe1012335
Porter932192
Johnson7732177
Hendricks7353165
Vigo6736106
Monroe604854
Madison5858125
Clark575986
Delaware5535108
LaPorte5291105
Kosciusko512948
Howard417680
Bartholomew380065
Warrick364374
Wayne362893
Floyd360279
Marshall343150
Grant326753
Cass323232
Hancock320663
Noble292450
Boone282056
Henry280741
Dubois271934
Jackson266638
Morgan259246
Dearborn252832
Gibson220333
Shelby216661
Knox212122
DeKalb210838
Lawrence205951
Clinton204025
Wabash195224
Adams192724
Miami191218
Daviess176747
Montgomery171429
Steuben168616
Jasper167717
Harrison167025
Ripley167022
Fayette165839
Whitley162417
LaGrange159534
Huntington153311
White151224
Putnam147831
Decatur145246
Wells145035
Randolph143724
Clay140426
Jefferson139719
Posey135722
Scott129725
Greene121054
Jay115516
Sullivan111418
Jennings106315
Starke104328
Spencer9678
Fulton96419
Fountain9588
Washington9019
Perry89221
Carroll81313
Franklin80228
Orange77028
Vermillion74911
Owen72210
Parke7056
Tipton68327
Blackford66116
Rush6488
Newton62513
Pike59321
Pulaski49720
Benton4483
Brown4226
Martin4006
Crawford3611
Union3032
Warren2893
Switzerland2825
Ohio2507
Unassigned0285